Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Carvedilol Posology on Portal Hypertension
NCT06015373Completed
- Sponsor
- Hospital de São João
- Start
- Jun 2023
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of carvedilol in Portal Hypertension (PH), sponsored by Hospital de São João. Primary endpoint: Spleen Stiffness Measurement. Started Jun 2023; status: completed.
02
Drugs
carvedilol
03
Conditions
Portal Hypertension (PH)
Beyond the preview
Go deeper on NCT06015373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06015373.